# | Title | Journal | Year | Citations |
---|
1 | The Economic Burden of Asthma in the United States, 2008–2013 | Annals of the American Thoracic Society | 2018 | 564 |
2 | The Global Burden of Respiratory Disease | Annals of the American Thoracic Society | 2014 | 536 |
3 | Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals | Annals of the American Thoracic Society | 2019 | 458 |
4 | The Gut–Lung Axis in Respiratory Disease | Annals of the American Thoracic Society | 2015 | 416 |
5 | Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis | Annals of the American Thoracic Society | 2017 | 400 |
6 | Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography | Annals of the American Thoracic Society | 2015 | 390 |
7 | Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment | Annals of the American Thoracic Society | 2021 | 306 |
8 | Early Warning System Scores for Clinical Deterioration in Hospitalized Patients: A Systematic Review | Annals of the American Thoracic Society | 2014 | 274 |
9 | The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry | Annals of the American Thoracic Society | 2016 | 270 |
10 | The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections | Annals of the American Thoracic Society | 2015 | 269 |
11 | Barriers and Strategies for Early Mobilization of Patients in Intensive Care Units | Annals of the American Thoracic Society | 2016 | 269 |
12 | A Comprehensive Analysis of the Impact ofPseudomonas aeruginosaColonisation on Prognosis in Adult Bronchiectasis | Annals of the American Thoracic Society | 2015 | 258 |
13 | Sarcoidosis in America. Analysis Based on Health Care Use | Annals of the American Thoracic Society | 2016 | 257 |
14 | Safety of Patient Mobilization and Rehabilitation in the Intensive Care Unit. Systematic Review with Meta-Analysis | Annals of the American Thoracic Society | 2017 | 255 |
15 | Aging of the Immune System. Mechanisms and Therapeutic Targets | Annals of the American Thoracic Society | 2016 | 253 |
16 | The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design | Annals of the American Thoracic Society | 2020 | 245 |
17 | Etiology of Non–Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity | Annals of the American Thoracic Society | 2015 | 233 |
18 | Standardizing Nasal Nitric Oxide Measurement as a Test for Primary Ciliary Dyskinesia | Annals of the American Thoracic Society | 2013 | 222 |
19 | Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program | Annals of the American Thoracic Society | 2015 | 218 |
20 | Changes in Cystic Fibrosis Airway Microbiota at Pulmonary Exacerbation | Annals of the American Thoracic Society | 2013 | 210 |
21 | Bronchopulmonary Dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases | Annals of the American Thoracic Society | 2014 | 206 |
22 | Predictors of Mortality in Hospitalized Adults with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis | Annals of the American Thoracic Society | 2013 | 203 |
23 | Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity | Annals of the American Thoracic Society | 2021 | 202 |
24 | Effects of Marijuana Smoking on the Lung | Annals of the American Thoracic Society | 2013 | 199 |
25 | Cystic Fibrosis Foundation Pulmonary Guideline. Pharmacologic Approaches to Prevention and Eradication of Initial Pseudomonas aeruginosa Infection | Annals of the American Thoracic Society | 2014 | 197 |
26 | Obesity Impairs the Adaptive Immune Response to Influenza Virus | Annals of the American Thoracic Society | 2017 | 197 |
27 | A Human Breathing Lung-on-a-Chip | Annals of the American Thoracic Society | 2015 | 190 |
28 | Management of Acute Right Ventricular Failure in the Intensive Care Unit | Annals of the American Thoracic Society | 2014 | 187 |
29 | A Novel Microbiota Stratification System Predicts Future Exacerbations in Bronchiectasis | Annals of the American Thoracic Society | 2014 | 183 |
30 | Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China | Annals of the American Thoracic Society | 2020 | 181 |
31 | Defining Modern Pulmonary Rehabilitation. An Official American Thoracic Society Workshop Report | Annals of the American Thoracic Society | 2021 | 176 |
32 | Antibiotic Management of Lung Infections in Cystic Fibrosis. I. The Microbiome, Methicillin-Resistant Staphylococcus aureus, Gram-Negative Bacteria, and Multiple Infections | Annals of the American Thoracic Society | 2014 | 175 |
33 | Airway Epithelial Differentiation and Mucociliary Clearance | Annals of the American Thoracic Society | 2018 | 173 |
34 | Blood Eosinophil Count Is a Useful Biomarker to Identify Patients with Severe Eosinophilic Asthma | Annals of the American Thoracic Society | 2014 | 172 |
35 | Quantitative Computed Tomography Measures of Pectoralis Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease. A Cross-Sectional Study | Annals of the American Thoracic Society | 2014 | 168 |
36 | The Loss of Topography in the Microbial Communities of the Upper Respiratory Tract in the Elderly | Annals of the American Thoracic Society | 2014 | 163 |
37 | Effects of Opioids on Breathlessness and Exercise Capacity in Chronic Obstructive Pulmonary Disease. A Systematic Review | Annals of the American Thoracic Society | 2015 | 163 |
38 | Pulse Oximetry for Monitoring Patients with COVID-19 at Home. Potential Pitfalls and Practical Guidance | Annals of the American Thoracic Society | 2020 | 162 |
39 | Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century | Annals of the American Thoracic Society | 2014 | 160 |
40 | Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008–2015 | Annals of the American Thoracic Society | 2020 | 159 |
41 | Inhaled Antibiotics for Lower Airway Infections | Annals of the American Thoracic Society | 2014 | 158 |
42 | Diagnostic Yield and Complications of Transbronchial Lung Cryobiopsy for Interstitial Lung Disease: A Systematic Review and Meta-analysis | Annals of the American Thoracic Society | 2016 | 158 |
43 | Inhaled Amikacin for Treatment of Refractory Pulmonary Nontuberculous Mycobacterial Disease | Annals of the American Thoracic Society | 2014 | 156 |
44 | An Official American Thoracic Society Workshop Report: Optimal Lung Function Tests for Monitoring Cystic Fibrosis, Bronchopulmonary Dysplasia, and Recurrent Wheezing in Children Less Than 6 Years of Age | Annals of the American Thoracic Society | 2013 | 155 |
45 | Cardiopulmonary Exercise Testing and Surgery | Annals of the American Thoracic Society | 2017 | 155 |
46 | Cardiopulmonary Exercise Testing: Basics of Methodology and Measurements | Annals of the American Thoracic Society | 2017 | 154 |
47 | A Steady Increase in Nontuberculous Mycobacteriosis Mortality and Estimated Prevalence in Japan | Annals of the American Thoracic Society | 2014 | 153 |
48 | The Cystic Fibrosis Lung Microbiome | Annals of the American Thoracic Society | 2014 | 149 |
49 | Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis | Annals of the American Thoracic Society | 2016 | 148 |
50 | Lung Extracellular Matrix and Fibroblast Function | Annals of the American Thoracic Society | 2015 | 145 |